Clinical Trial Update: A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 trial update of tirzepatide in Chinese participants with Type 2 diabetes mellitus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2023-07-06